Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2024

末梢血管用デバイスの世界市場予測(~2024年)

◆タイトル:Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2024
◆商品コード:MD 1254
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年2月28日
◆ページ数:191
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

末梢血管用デバイスの世界市場は、2019年の103億米ドルから2024年には144億米ドルに達し、この期間中6.8%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、高齢者人口の急激な増加とそれに伴う末梢血管疾患の罹患率の増加、新たな先進製品の認可、そして低侵襲手術の選択の拡大が考えられます。当調査レポートでは、末梢血管用デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類(血管形成術用バルーン、ステント、カテーテル、プラークモディフィケーション、血流変化、IVCフィルター、ガイドワイヤー)分析、末梢血管用デバイスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Peripheral vascular devices market to register a CAGR of 6.8% from 2019 to 2024”The peripheral vascular devices market is projected to reach USD 14.4 billion by 2024 from USD 10.3 billion in 2019, at a CAGR of 6.8% during the forecast period. The rapid growth in the geriatric population and the associated increase in the prevalence of peripheral vascular diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries are driving the growth of the peripheral vascular devices.

“Atherectomy devices accounted for the larger share of the plaque modification devices market in 2018”
On the basis of type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices. In 2018, the atherectomy devices segment accounted for the larger market share mainly due to the increasing incidence of atherosclerosis as a result of the rising global prevalence of obesity.

“Embolic protection devices accounted for the largest share of the peripheral vascular devices market in 2018”
On the basis of type, the hemodynamic flow alteration devices market is segmented into embolic protection devices and chronic total occlusion devices. In 2018, the embolic protection devices segment accounted for the larger share of the hemodynamic flow alteration devices market. This can be attributed to the advantages of EPDs over CTO devices, such as the ability to capture embolic debris without interrupting continuous blood flow.

“North America dominates the peripheral vascular devices market”
North America, which includes the US and Canada, accounted for the largest share of the peripheral vascular devices market in 2018. The large share of this market segment can be attributed to the rising incidence of peripheral vascular diseases (PVDs), growing geriatric population, and the strong presence of industry players in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1: 20% , Tier 2: 45%, and Tier 3: 35%
• By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
• By Region: North America: 35%, Europe: 24%, Asia: 25%, and the RoW: 16%

The major players operating in this market are Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).

Research Coverage
This report studies the peripheral vascular devices market based on product and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total peripheral vascular devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the peripheral vascular devices offered by the top 10 players in the market. The report analyzes the peripheral vascular devices market by product and region

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various peripheral vascular devices across key geographic regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the peripheral vascular devices market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the peripheral vascular devices market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.2.1 MARKETS COVERED 20
1.2.2 REGIONAL COVERAGE 20
1.2.3 YEARS CONSIDERED FOR THE STUDY 21
1.3 CURRENCY 21
1.4 LIMITATIONS 21
1.5 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 SECONDARY DATA 23
2.1.1 KEY DATA FROM SECONDARY SOURCES 23
2.2 PRIMARY DATA 24
2.2.1 KEY DATA FROM PRIMARY SOURCES 25
2.3 MARKET SIZE ESTIMATION 25
2.3.1 BOTTOM-UP APPROACH 26
2.3.2 TOP-DOWN APPROACH 26
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.5 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 35
4.1 PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW 35
4.2 NORTH AMERICA: ANGIOPLASTY STENTS MARKET (2018) 36
4.3 GEOGRAPHICAL SNAPSHOT OF THE PERIPHERAL VASCULAR DEVICES MARKET 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases 39
5.2.1.2 Product approvals 39
5.2.1.3 Increasing prevalence of diabetes 40
5.2.2 RESTRAINTS 41
5.2.2.1 Product failures and recalls 41

5.2.3 OPPORTUNITIES 41
5.2.3.1 Emerging markets 41
5.2.4 CHALLENGES 42
5.2.4.1 Availability of alternative treatments 42
6 ANGIOPLASTY BALLOONS MARKET, BY TYPE 43
6.1 INTRODUCTION 44
6.2 OLD/NORMAL BALLOONS 45
6.2.1 OLD/NORMAL BALLOONS WILL CONTINUE TO DOMINATE THE ANGIOPLASTY BALLOONS MARKET IN 2024 45
6.3 CUTTING AND SCORING BALLOONS 46
6.3.1 CUTTING BALLOONS ARE USED TO TREAT ATHEROSCLEROSIS 46
6.4 DRUG-ELUTING BALLOONS 47
6.4.1 DRUG-ELUTING BALLOONS TO WITNESS THE HIGHEST GROWTH IN THE ANGIOPLASTY BALLOONS MARKET DURING THE FORECAST PERIOD 47
7 ANGIOPLASTY STENTS MARKET, BY TYPE 48
7.1 INTRODUCTION 49
7.2 DRUG-ELUTING STENTS 50
7.2.1 DRUG-ELUTING STENTS TO WITNESS HIGHER ADOPTION PRIMARILY DUE TO THE REDUCED RESTENOSIS RATE ASSOCIATED WITH THESE PRODUCTS 50
7.3 BARE-METAL STENTS 51
7.3.1 INCREASING USE OF DRUG-ELUTING STENTS TO RESTRAIN MARKET GROWTH 51
7.3.2 BARE-METAL STENTS, BY DELIVERY PLATFORM 52
7.3.2.1 Balloon-expandable stents 52
7.3.2.2 Self-expandable stents 53
8 CATHETERS MARKET, BY TYPE 54
8.1 INTRODUCTION 55
8.2 ANGIOGRAPHY CATHETERS 56
8.2.1 ANGIOGRAPHY CATHETERS TO DOMINATE THE CATHETERS MARKET DURING THE FORECAST PERIOD 56
8.3 GUIDING CATHETERS 57
8.3.1 GUIDING CATHETERS TO ACCOUNT FOR THE SECOND-LARGEST SHARE OF THE CATHETERS MARKET DURING THE FORECAST PERIOD 57
8.4 IVUS/OCT CATHETERS 57
8.4.1 IVUS/OCT CATHETERS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 57

9 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE 59
9.1 INTRODUCTION 60
9.2 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS 61
9.2.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 61
9.3 THORACIC AORTIC ANEURYSM STENT GRAFTS 62
9.3.1 INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO DRIVE MARKET GROWTH IN THE COMING YEARS 62
10 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE 63
10.1 INTRODUCTION 64
10.2 RETRIEVABLE FILTERS 65
10.2.1 RETRIEVABLE FILTERS SEGMENT TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 65
10.3 PERMANENT FILTERS 65
10.3.1 RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER THEIR SALES DURING THE FORECAST PERIOD 65
11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 67
11.1 INTRODUCTION 68
11.2 ATHERECTOMY DEVICES 69
11.2.1 INCREASING INCIDENCE OF ATHEROSCLEROSIS AS A RESULT OF THE RISING GLOBAL PREVALENCE OF OBESITY—A KEY MARKET DRIVER 69
11.3 THROMBECTOMY DEVICES 70
11.3.1 GROWING DVT INCIDENCE TO DRIVE THE ADOPTION OF THROMBECTOMY DEVICES 70
12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 71
12.1 INTRODUCTION 72
12.2 EMBOLIC PROTECTION DEVICES 72
12.2.1 INCREASING INVESTMENTS IN NEW TECHNOLOGY DEVELOPMENT AND THE GROWING NUMBER OF REGULATORY APPROVALS FOR THESE DEVICES TO DRIVE MARKET GROWTH 72
12.3 CHRONIC TOTAL OCCLUSION (CTO) DEVICES 73
12.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF CTO DEVICES TO DRIVE MARKET GROWTH 73
13 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 75
13.1 INTRODUCTION 76
13.2 GUIDEWIRES 77
13.3 VASCULAR CLOSURE DEVICES 78
13.4 INTRODUCER SHEATHS 79
13.5 BALLOON INFLATION DEVICES 80

14 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION 82
14.1 INTRODUCTION 83
14.2 NORTH AMERICA 84
14.2.1 US 88
14.2.1.1 Favorable reimbursement scenario ensures device adoption in the US 88
14.2.2 CANADA 91
14.2.2.1 Rising prevalence of target diseases will drive market growth 91
14.3 EUROPE 95
14.3.1 GERMANY 99
14.3.1.1 Increase in geriatric and obese populations will contribute to device demand 99
14.3.2 FRANCE 102
14.3.2.1 Incidence of PE and DVT will increase, corresponding to growth in France’s geriatric population 102
14.3.3 UK 106
14.3.3.1 Increasing incidence of peripheral vascular diseases to support market growth in the UK 106
14.3.4 SPAIN 109
14.3.4.1 Rising geriatric population to increase the demand for peripheral vascular devices in Spain 109
14.3.5 ITALY 112
14.3.5.1 Increasing health expenditure and rising diabetes prevalence are the major factors driving market growth in Italy 112
14.3.6 REST OF EUROPE 116
14.4 ASIA PACIFIC 120
14.4.1 JAPAN 124
14.4.1.1 Presence of a large geriatric population – A major factor supporting market growth in Japan 124
14.4.2 CHINA 127
14.4.2.1 Growing target patient population in China to drive market growth 127
14.4.3 INDIA 130
14.4.3.1 Increasing prevalence of diabetes to drive the adoption of peripheral vascular devices 130
14.4.4 REST OF ASIA PACIFIC 134
14.5 REST OF THE WORLD 137
14.5.1 LATIN AMERICA 140
14.5.1.1 Growing geriatric population and the subsequent increase in the prevalence of peripheral artery diseases to drive market growth 140
14.5.2 MIDDLE EAST & AFRICA 143
14.5.2.1 Increasing prevalence of diabetes to drive market growth 143

15 COMPETITIVE LANDSCAPE 147
15.1 OVERVIEW 147
15.2 MARKET SHARE ANALYSIS, 2017 148
15.3 COMPETITIVE SCENARIO 149
15.3.1 PRODUCT LAUNCHES AND APPROVALS, 2015–2018 149
15.3.2 ACQUISITIONS, 2015–2018 149
15.3.3 AGREEMENTS, 2015–2018 149
15.3.4 EXPANSIONS, 2015–2018 150
15.4 COMPETITIVE LEADERSHIP MAPPING (2017) 150
15.4.1 VENDOR INCLUSION CRITERIA 150
15.4.2 VISIONARY LEADERS 150
15.4.3 INNOVATORS 150
15.4.4 DYNAMIC DIFFERENTIATORS 151
15.4.5 EMERGING COMPANIES 151
15.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017) 152
15.5.1 PROGRESSIVE COMPANIES 152
15.5.2 STARTING BLOCKS 152
15.5.3 RESPONSIVE COMPANIES 152
15.5.4 DYNAMIC COMPANIES 152
16 COMPANY PROFILES 154
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
16.1 MEDTRONIC 154
16.2 BOSTON SCIENTIFIC CORPORATION 158
16.3 ABBOTT LABORATORIES 162
16.4 BECTON, DICKINSON AND COMPANY 165
16.5 TERUMO CORPORATION 168
16.6 CORDIS (A SUBSIDIARY OF CARDINAL HEALTH, INC.) 171
16.7 B. BRAUN MELSUNGEN AG 174
16.8 IVASCULAR 176
16.9 BIOSENSORS INTERNATIONAL GROUP LTD. 178
16.10 BIOTRONIK 179
16.11 PENUMBRA, INC. 180

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

17 APPENDIX 182
17.1 INSIGHTS OF INDUSTRY EXPERTS 182
17.2 DISCUSSION GUIDE 183
17.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 187
17.4 AVAILABLE CUSTOMIZATIONS 189
17.5 RELATED REPORTS 189
17.6 AUTHOR DETAILS 190

LIST OF TABLES

TABLE 1 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 39
TABLE 2 PRODUCT APPROVALS IN THE PERIPHERAL VASCULAR DEVICES MARKET,
2015–2018 40
TABLE 3 DIABETES POPULATION, BY REGION, 2000 VS. 2030 40
TABLE 4 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 44
TABLE 5 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2017–2024 (USD MILLION) 44
TABLE 6 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2017–2024 (USD MILLION) 45
TABLE 7 CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2017–2024 (USD MILLION) 46
TABLE 8 DRUG-ELUTING BALLOONS MARKET, BY REGION, 2017–2024 (USD MILLION) 47
TABLE 9 ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 49
TABLE 10 ANGIOPLASTY STENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 49
TABLE 11 ANGIOPLASTY STENTS MARKET, BY REGION, 2017–2024 (THOUSAND UNITS) 50
TABLE 12 DRUG-ELUTING STENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 51
TABLE 13 BARE-METAL STENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 51
TABLE 14 BARE-METAL STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 52
TABLE 15 BALLOON-EXPANDABLE STENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 52
TABLE 16 SELF-EXPANDABLE STENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 53
TABLE 17 CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 55
TABLE 18 CATHETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 55
TABLE 19 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 20 GUIDING CATHETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 21 IVUS/OCT CATHETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 58
TABLE 22 EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 60
TABLE 23 EVAR STENT GRAFTS MARKET, BY REGION, 2017–2024 (USD MILLION) 60
TABLE 24 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2017–2024 (USD MILLION) 61
TABLE 25 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2017–2024 (USD MILLION) 62
TABLE 26 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 64
TABLE 27 INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2017–2024 (USD MILLION) 64
TABLE 28 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2017–2024 (USD MILLION) 65
TABLE 29 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2017–2024 (USD MILLION) 66
TABLE 30 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 68
TABLE 31 PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 68
TABLE 32 ATHERECTOMY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 33 THROMBECTOMY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 70
TABLE 34 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 72
TABLE 35 EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 73
TABLE 36 CHRONIC OCCLUSION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 74
TABLE 37 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 76
TABLE 38 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 76
TABLE 39 GUIDEWIRES MARKET, BY REGION, 2017–2024 (USD MILLION) 77
TABLE 40 GUIDEWIRES MARKET, BY REGION, 2015–2024 (THOUSAND UNITS) 77
TABLE 41 VASCULAR CLOSURE DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 78
TABLE 42 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2015–2024 (THOUSAND UNITS) 78
TABLE 43 INTRODUCER SHEATHS MARKET, BY REGION, 2017–2024 (USD MILLION) 79
TABLE 44 INTRODUCER SHEATHS MARKET, BY REGION, 2015–2024 (THOUSAND UNITS) 79
TABLE 45 BALLOON INFLATION DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 80
TABLE 46 BALLOON INFLATION DEVICES MARKET, BY REGION,
2017–2024 (THOUSAND UNITS) 81
TABLE 47 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 83
TABLE 48 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 85
TABLE 49 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2017–2024 (USD MILLION) 85
TABLE 50 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 85
TABLE 51 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 86
TABLE 52 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 86
TABLE 53 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 86
TABLE 54 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 87
TABLE 55 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 87
TABLE 56 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 87
TABLE 57 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 88
TABLE 58 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 59 US: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 60 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 89
TABLE 61 US: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 90
TABLE 62 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 90
TABLE 63 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 90
TABLE 64 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 91
TABLE 65 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 91
TABLE 66 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 92
TABLE 67 CANADA: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 92
TABLE 68 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 92
TABLE 69 CANADA: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 93
TABLE 70 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 93
TABLE 71 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 94
TABLE 72 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 94
TABLE 73 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 95
TABLE 74 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 96
TABLE 75 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 96
TABLE 76 EUROPE: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 96
TABLE 77 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 97
TABLE 78 EUROPE: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 97
TABLE 79 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 97
TABLE 80 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 98
TABLE 81 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 98
TABLE 82 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2017–2024 (USD MILLION) 99
TABLE 83 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 99
TABLE 84 GERMANY: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 100
TABLE 85 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 100
TABLE 86 GERMANY: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 100
TABLE 87 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 101
TABLE 88 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 101
TABLE 89 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 102
TABLE 90 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 103
TABLE 91 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 103
TABLE 92 FRANCE: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 103
TABLE 93 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 104
TABLE 94 FRANCE: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 104
TABLE 95 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 104
TABLE 96 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 105
TABLE 97 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 105
TABLE 98 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 106
TABLE 99 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 107
TABLE 100 UK: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 107
TABLE 101 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 107
TABLE 102 UK: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 108
TABLE 103 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 108
TABLE 104 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 108
TABLE 105 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 109
TABLE 106 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 109
TABLE 107 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 108 SPAIN: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 109 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 110 SPAIN: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 111
TABLE 111 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 111
TABLE 112 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 111
TABLE 113 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 112
TABLE 114 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 112
TABLE 115 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 116 ITALY: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 117 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 118 ITALY: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 114
TABLE 119 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 114
TABLE 120 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 115
TABLE 121 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 115
TABLE 122 ROE: HEALTH EXPENDITURE, BY COUNTRY, 2007 VS. 2015 (% OF GDP) 116
TABLE 123 ROE: PERCENTAGE OF GERIATRIC POPULATION TO THE TOTAL POPULATION,
BY COUNTRY, 2015 VS. 2030 (MILLION) 116
TABLE 124 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 117
TABLE 125 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 117
TABLE 126 ROE: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 117
TABLE 127 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 118
TABLE 128 ROE: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 118
TABLE 129 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 118
TABLE 130 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 119
TABLE 131 ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 119
TABLE 132 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 121
TABLE 133 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2017–2024 (USD MILLION) 121
TABLE 134 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 121
TABLE 135 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 122
TABLE 136 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 122
TABLE 137 ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 122
TABLE 138 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 123
TABLE 139 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 140 ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 141 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 124
TABLE 142 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 143 JAPAN: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 144 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 145 JAPAN: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 126
TABLE 146 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 126
TABLE 147 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 126
TABLE 148 JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 127
TABLE 149 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 128
TABLE 150 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 128
TABLE 151 CHINA: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 128
TABLE 152 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 129
TABLE 153 CHINA: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 129
TABLE 154 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 129
TABLE 155 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 130
TABLE 156 CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 130
TABLE 157 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 131
TABLE 158 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 131
TABLE 159 INDIA: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 160 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 161 INDIA: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 162 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 133
TABLE 163 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 133
TABLE 164 INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 133
TABLE 165 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 134
TABLE 166 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 134
TABLE 167 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 135
TABLE 168 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 135
TABLE 169 REST OF ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 135
TABLE 170 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 136
TABLE 171 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 136
TABLE 172 REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 136
TABLE 173 ROW: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 137
TABLE 174 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2017–2024 (USD MILLION) 137
TABLE 175 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 138
TABLE 176 ROW: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 138
TABLE 177 ROW: EVAR STENT GRAFTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 138
TABLE 178 ROW: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 139
TABLE 179 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 139
TABLE 180 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 139
TABLE 181 ROW: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 140
TABLE 182 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2017–2024 (USD MILLION) 141
TABLE 183 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 141
TABLE 184 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 141
TABLE 185 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 142
TABLE 186 LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 142
TABLE 187 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 142
TABLE 188 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 143
TABLE 189 LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 143
TABLE 190 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 144
TABLE 191 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 144
TABLE 192 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2017–2024 (USD MILLION) 144
TABLE 193 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 145
TABLE 194 MIDDLE EAST & AFRICA: IVC FILTERS MARKET, BY TYPE,
2017–2024 (USD MILLION) 145
TABLE 195 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 145
TABLE 196 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 146
TABLE 197 MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 146


LIST OF FIGURES

FIGURE 1 PERIPHERAL VASCULAR DEVICES MARKET 20
FIGURE 2 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION 20
FIGURE 3 RESEARCH DESIGN 22
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 24
FIGURE 5 PERIPHERAL VASCULAR DEVICES MARKET: BOTTOM-UP APPROACH 26
FIGURE 6 PERIPHERAL VASCULAR DEVICES MARKET: TOP-DOWN APPROACH 26
FIGURE 7 DATA TRIANGULATION METHODOLOGY 27
FIGURE 8 ANGIOPLASTY STENTS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 29
FIGURE 9 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET,
BY TYPE, 2019 VS. 2024 (USD MILLION) 30
FIGURE 10 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 30
FIGURE 11 CATHETERS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 31
FIGURE 12 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 31
FIGURE 13 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 32
FIGURE 14 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 32
FIGURE 15 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 33
FIGURE 16 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2019 VS. 2024 (USD MILLION) 33
FIGURE 17 INCREASING PREVALENCE OF PERIPHERAL VASCULAR DISEASES IS EXPECTED
TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 35
FIGURE 18 DRUG-ELUTING STENTS DOMINATED THE NORTH AMERICAN ANGIOPLASTY STENTS MARKET IN 2018 36
FIGURE 19 COUNTRIES IN ASIA PACIFIC TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 37
FIGURE 20 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 38
FIGURE 21 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2019 VS 2024 83
FIGURE 22 NORTH AMERICA: MARKET SNAPSHOT 84
FIGURE 23 ASIA PACIFIC: MARKET SNAPSHOT 120
FIGURE 24 KEY DEVELOPMENTS IN THE PERIPHERAL VASCULAR DEVICES MARKET FROM 2015 TO 2019 147
FIGURE 25 SHARE OF COMPANIES IN THE PERIPHERAL VASCULAR DEVICES MARKET, 2017 148
FIGURE 26 MNM DIVE-VENDOR COMPARISON MATRIX: PERIPHERAL VASCULAR DEVICES MARKET 151
FIGURE 27 MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: PERIPHERAL VASCULAR DEVICES MARKET 153
FIGURE 28 MEDTRONIC: COMPANY SNAPSHOT 154
FIGURE 29 BOSTON SCIENTIFIC: COMPANY SNAPSHOT 158

FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT 162
FIGURE 31 BD: COMPANY SNAPSHOT 165
FIGURE 32 TERUMO CORPORATION: COMPANY SNAPSHOT 168
FIGURE 33 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT 171
FIGURE 34 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 174
FIGURE 35 PENUMBRA, INC.: COMPANY SNAPSHOT 180


★調査レポート[末梢血管用デバイスの世界市場予測(~2024年)] ( Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2024 / MD 1254) 販売に関する免責事項
[末梢血管用デバイスの世界市場予測(~2024年)] ( Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2024 / MD 1254) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆